Patients with a higher mGPS had a significantly lower pre‐treatment SMD and a lower pre‐treatment SMI, with marginal significance ( Figure 2 A and 2 B).
← all excerpts
Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
1
—
—